Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael McNaughton

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Health Physics|April 30, 2019
Validation Tests of Resuspension Models for a Finite and Infinite SiteJeffrey J Whicker, Michael McNaughton, Elizabeth Ruedig, et al.
Journal of Medicinal Chemistry|September 12, 2008
Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligandsPeter Karellas, Michael McNaughton, Stephen P Baker, et al.
Bioorganic & Medicinal Chemistry|November 8, 2003
Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cellsLars Engman, Nawaf Al-Maharik, Michael McNaughton, et al.
Anti-Cancer Drugs|February 6, 2003
Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidantsLars Engman, Nawaf Al-Maharik, Michael McNaughton, et al.
Journal of Medicinal Chemistry|December 30, 2003
Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growthMichael McNaughton, Lars Engman, Anne Birmingham, et al.
Health Physics|June 28, 2013
Addressing nuclides not in the CAP88-PC Version-3 libraryMichael McNaughton, Burgandy Brock, William Eisele, et al.
Health Physics|June 28, 2013
Validation test for CAP88 predictions of tritium dispersion at Los Alamos National LaboratoryErika Michelotti, Andrew Green, Jeffrey Whicker, et al.
Anti-Cancer Drugs|May 17, 2006
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compoundsLars Engman, Michael McNaughton, Malgorzata Gajewska, et al.
The Journal of Biological Chemistry|February 8, 2005
Substrate-assisted leaving group activation in enzyme-catalyzed N-glycosidic bond cleavageStefan Loverix, Paul Geerlings, Michael McNaughton, et al.
Sports Health|October 24, 2024
Sport-Related Injury and Performance Enhancing Substance Use by Young AthletesMichael McNaughton, Danielle Hunt, Becky Parmeter, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Health Physics|April 30, 2019
Validation Tests of Resuspension Models for a Finite and Infinite SiteJeffrey J Whicker, Michael McNaughton, Elizabeth Ruedig, et al.
Journal of Medicinal Chemistry|September 12, 2008
Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligandsPeter Karellas, Michael McNaughton, Stephen P Baker, et al.
Bioorganic & Medicinal Chemistry|November 8, 2003
Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cellsLars Engman, Nawaf Al-Maharik, Michael McNaughton, et al.
Anti-Cancer Drugs|February 6, 2003
Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidantsLars Engman, Nawaf Al-Maharik, Michael McNaughton, et al.
Journal of Medicinal Chemistry|December 30, 2003
Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growthMichael McNaughton, Lars Engman, Anne Birmingham, et al.
Health Physics|June 28, 2013
Addressing nuclides not in the CAP88-PC Version-3 libraryMichael McNaughton, Burgandy Brock, William Eisele, et al.
Health Physics|June 28, 2013
Validation test for CAP88 predictions of tritium dispersion at Los Alamos National LaboratoryErika Michelotti, Andrew Green, Jeffrey Whicker, et al.
Anti-Cancer Drugs|May 17, 2006
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compoundsLars Engman, Michael McNaughton, Malgorzata Gajewska, et al.
The Journal of Biological Chemistry|February 8, 2005
Substrate-assisted leaving group activation in enzyme-catalyzed N-glycosidic bond cleavageStefan Loverix, Paul Geerlings, Michael McNaughton, et al.
Sports Health|October 24, 2024
Sport-Related Injury and Performance Enhancing Substance Use by Young AthletesMichael McNaughton, Danielle Hunt, Becky Parmeter, et al.
Pageof 2